These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

764 related items for PubMed ID: 29611079

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
    Safwan M, Nwagu U, Collins K, Abouljoud M, Nagai S.
    Transplantation; 2019 Oct; 103(10):2121-2129. PubMed ID: 30747840
    [Abstract] [Full Text] [Related]

  • 4. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.
    Ahn J, Bhuket T, Mosadeghi S, Frenette C, Liu B, Wong RJ.
    Hepatol Int; 2016 Sep; 10(5):838-46. PubMed ID: 27221700
    [Abstract] [Full Text] [Related]

  • 5. Predictors of Waitlist Mortality in Portopulmonary Hypertension.
    DuBrock HM, Goldberg DS, Sussman NL, Bartolome SD, Kadry Z, Salgia RJ, Mulligan DC, Kremers WK, Kawut SM, Krowka MJ, Channick RN.
    Transplantation; 2017 Jul; 101(7):1609-1615. PubMed ID: 28207639
    [Abstract] [Full Text] [Related]

  • 6. Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation.
    Sundaram V, Jalan R, Wu T, Volk ML, Asrani SK, Klein AS, Wong RJ.
    Gastroenterology; 2019 Apr; 156(5):1381-1391.e3. PubMed ID: 30576643
    [Abstract] [Full Text] [Related]

  • 7. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK, DiNorcia J, Ji L, Groshen S, Levitsky J, Sung RS, Kim WR, Andreoni K, Mulligan D, Genyk YS.
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [Abstract] [Full Text] [Related]

  • 8. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
    Lucidi C, Ginanni Corradini S, Abraldes JG, Merli M, Tandon P, Ferri F, Parlati L, Lattanzi B, Poli E, Di Gregorio V, Farcomeni A, Riggio O.
    Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [Abstract] [Full Text] [Related]

  • 11. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.
    Lai YH, Duan WD, Yu Q, Ye S, Xiao NJ, Zhang DX, Huang ZQ, Yang ZY, Dong JH.
    World J Gastroenterol; 2015 May 28; 21(20):6296-303. PubMed ID: 26034365
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Improved posttransplant mortality after share 35 for liver transplantation.
    Kwong AJ, Goel A, Mannalithara A, Kim WR.
    Hepatology; 2018 Jan 28; 67(1):273-281. PubMed ID: 28586179
    [Abstract] [Full Text] [Related]

  • 15. Serum sodium and survival benefit of liver transplantation.
    Sharma P, Schaubel DE, Goodrich NP, Merion RM.
    Liver Transpl; 2015 Mar 28; 21(3):308-13. PubMed ID: 25504743
    [Abstract] [Full Text] [Related]

  • 16. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.
    Leise MD, Kim WR, Kremers WK, Larson JJ, Benson JT, Therneau TM.
    Gastroenterology; 2011 Jun 28; 140(7):1952-60. PubMed ID: 21334338
    [Abstract] [Full Text] [Related]

  • 17. Improved Waitlist Outcomes in Liver Transplant Patients With Mid-MELD-Na Scores Listed in Centers Receptive to Use of Organs Donated After Circulatory Death.
    Miyake K, Chau LC, Trudeau S, Kitajima T, Wickramaratne N, Shimada S, Nassar A, Gonzalez HC, Venkat D, Moonka D, Yoshida A, Abouljoud MS, Nagai S.
    Transplantation; 2024 Sep 01; 108(9):1943-1953. PubMed ID: 38409687
    [Abstract] [Full Text] [Related]

  • 18. Survival outcomes in liver transplant recipients with Model for End-stage Liver Disease scores of 40 or higher: a decade-long experience.
    Panchal HJ, Durinka JB, Patterson J, Karipineni F, Ashburn S, Siskind E, Ortiz J.
    HPB (Oxford); 2015 Dec 01; 17(12):1074-84. PubMed ID: 26373873
    [Abstract] [Full Text] [Related]

  • 19. Improved retransplant outcomes: early evidence of the share35 impact.
    Brooks JT, Koizumi N, Neglia E, Gdoura B, Wong TW, Kwon C, Smith TE, Ortiz J.
    HPB (Oxford); 2018 Jul 01; 20(7):649-657. PubMed ID: 29500002
    [Abstract] [Full Text] [Related]

  • 20. The impact of MELD exception points for hydrothorax on posttransplant mortality: a propensity score-matched analysis.
    Fathma S, Boateng S, Amatya A, Ameyaw P, Banini BA.
    Eur J Gastroenterol Hepatol; 2024 Aug 01; 36(8):1016-1021. PubMed ID: 38829948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.